angiotensin II type 1 receptor blockers

Preferred Label : angiotensin II type 1 receptor blockers;

MeSH definition : Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.;

MeSH synonym : angiotensin ii type 1 receptor antagonists; type 1 angiotensin receptor blockers; type 1 angiotensin receptor antagonists; Angiotensin 2 Type 1 Receptor Antagonists; Angiotensin II Type 1 Receptor Antagonist; Angiotensin II Type 1 Receptor Blocker;

MeSH hyponym : selective angiotensin II receptor antagonists; Sartans; Sartan;

Wikipedia link : https://en.wikipedia.org/wiki/Sartans;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D047228;

UMLS CUI

C1449680;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- angiotensin II receptor blocker [COVID-19 Thesaurus concept]
Indexing information
- 3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- allisartan isoproxil [MeSH Supplementary Concept]
- azilsartan medoxomil [MeSH Supplementary Concept]
- embusartan [MeSH Supplementary Concept]
- eprosartan mesylate dihydrate [MeSH Supplementary Concept]
- fonsartan [MeSH Supplementary Concept]
- forasartan [MeSH Supplementary Concept]
- telmisartan amlodipine combination [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptor, angiotensin, type 1 [MeSH Descriptor]
Record concept(s)
- angiotensin II type 1 receptor blockers [MeSH concept]
- selective angiotensin II receptor antagonists [MeSH concept]
See also
- angiotensin-converting enzyme inhibitors [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-sarcosine-8-isoleucine angiotensin ii [MeSH Descriptor]
- 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-2,3-diazaspiro(4.4)nonane-1,4-dione [MeSH Supplementary Concept]
- 3-((2'-(benzoylaminosulfonyl)(1,1'-biphenyl)-4-yl)methyl)-2-butyl-2,3-diazaspiro(4.4)nonane-1,4-dione [MeSH Supplementary Concept]
- 3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3H-imidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)(1,1'-biphenyl)-2-sulfonamide [MeSH Supplementary Concept]
- 57G709 [MeSH Supplementary Concept]
- 606A compound [MeSH Supplementary Concept]
- A 81988 [MeSH Supplementary Concept]
- Amlodipine Besylate, Olmesartan Medoxomil Drug Combination [MeSH Descriptor]
- BMS 183920 [MeSH Supplementary Concept]
- GR 117289 [MeSH Supplementary Concept]
- HN 65021 [MeSH Supplementary Concept]
- Irbesartan [MeSH Descriptor]
- KD3 671 [MeSH Supplementary Concept]
- KR 31080 [MeSH Supplementary Concept]
- KRH 594 [MeSH Supplementary Concept]
- LR B-081 [MeSH Supplementary Concept]
- N-(2-(6-((2-ethyl-5,7-dimethyl-3H-imidazo(4,5-b)pyridin-3-yl)methyl)quinolin-2-yl))trifluoromethanesulfonamide [MeSH Supplementary Concept]
- Olmesartan Medoxomil [MeSH Descriptor]
- TH 142177 [MeSH Supplementary Concept]
- Telmisartan [MeSH Descriptor]
- UR 7247 [MeSH Supplementary Concept]
- UR 7280 [MeSH Supplementary Concept]
- Valsartan [MeSH Descriptor]
- YM358 [MeSH Supplementary Concept]
- ZD 7155 [MeSH Supplementary Concept]
- abbott 81282 [MeSH Supplementary Concept]
- azilsartan medoxomil [MeSH Supplementary Concept]
- candesartan [MeSH Supplementary Concept]
- candesartan cilexetil [MeSH Supplementary Concept]
- enoltasosartan [MeSH Supplementary Concept]
- losartan [MeSH Descriptor]
- olmesartan [MeSH Supplementary Concept]
- saprisartan potassium [MeSH Supplementary Concept]
- saralasin [MeSH Descriptor]
- tasosartan [MeSH Supplementary Concept]
- telmisartan amlodipine combination [MeSH Supplementary Concept]
- telmisartan, hydrochlorothiazide drug combination [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients